The Aspergillus IgG antibody test detects IgG antibodies against Aspergillus species, a genus of fungi that can cause chronic lung infections and allergic reactions. It is primarily used to diagnose chronic pulmonary aspergillosis (CPA) and allergic bronchopulmonary aspergillosis (ABPA).
✅ Diagnosing chronic pulmonary aspergillosis (CPA)
✅ Assessing allergic bronchopulmonary aspergillosis (ABPA)
✅ Distinguishing active infection from colonization
| Result | Interpretation |
|---|---|
| Negative | No significant Aspergillus IgG detected (infection unlikely) |
| Borderline/Indeterminate | Possible early or low-level infection, may need repeat testing |
| Positive | Suggestive of past or current Aspergillus exposure, CPA, or ABPA |
🔹 False positives may occur due to cross-reactivity with other fungal infections.
🔹 False negatives can occur in immunocompromised patients who do not mount a strong antibody response.
Chronic Pulmonary Aspergillosis (CPA) → A long-term lung infection in people with pre-existing lung disease (e.g., TB, COPD, bronchiectasis).
Allergic Bronchopulmonary Aspergillosis (ABPA) → A hypersensitivity reaction seen in asthma and cystic fibrosis patients.
Aspergilloma (Fungal Ball) → A localized fungal mass in a lung cavity, often in patients with previous lung damage.
✔ Aspergillus IgM → May indicate recent or active infection.
✔ Galactomannan Antigen Test → Preferred for detecting invasive aspergillosis.
✔ Beta-D-Glucan Test → Broad fungal infection marker but not Aspergillus-specific.
✔ Fungal Culture & PCR → Identifies Aspergillus species directly from sputum or bronchoalveolar lavage (BAL).
✔ Chest CT Scan → Helps visualize aspergillomas, cavities, or nodules.
🔹 Evaluate clinical symptoms & risk factors (e.g., chronic lung disease, immunosuppression).
🔹 Consider further testing (CT scan, fungal culture, galactomannan test).
🔹 Initiate antifungal treatment if indicated (e.g., itraconazole, voriconazole for CPA or ABPA).
Original price was: ₹1,750.00.₹1,399.00Current price is: ₹1,399.00.